After Heparin: Protecting Consumers From the Risks of Substandard and Counterfeit Drugs

Jul 12, 2011
  • Description

Based on case studies, examines globalization and quality management trends in pharmaceutical manufacturing, barriers to Federal Drug Administration oversight, and the security of pharmaceutical distribution. Makes policy recommendations to ensure safety.